Active Somatosensory Exercise for Chronic Stroke (ActSens)
Effectiveness of Robotic-based ACTive somatoSENSory (Act.Sens) Retraining on Upper Limb Functions: Protocol for a Pilot Randomised Controlled Trial With Community-dwelling Stroke Survivors
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Ananda Sidarta, PhD
- Phone Number: +65 6904 1361
- Email: ananda.sidarta@ntu.edu.sg
Study Locations
-
-
-
Bukit Batok New Town, Singapore
- St Luke's Hospital
-
Singapore, Singapore
- AWWA Day Rehab Centre
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- First-time ischemic or haemorrhagic stroke survivors;
- Patients of at least 6-month post-stroke;
- Patients with severe to moderate sensory impairment as assessed by Erasmus Nottingham Sensory Assessment (≤ 6/8);
- Patients with arm motor impairment, shoulder abduction and elbow extension Medical Research Council (MRC) motor power grade 3-5;
Exclusion Criteria:
- Patients with bilateral impairment;
- Patients with high upper-limb spasticity (Ashworth scale > 2);
- Patients with unilateral neglect as assessed by Star Cancellation Test (score < 44);
- Patients with cognitive impairment as assessed by a 2-step instructions from the modified Mini Mental State Examination;
- Patients with a known history of mental disorders;
- Patients with the inability to perform upper arm activity due to excessive pain
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Active somatosensory training group
Chronic stroke patients will be randomized to receive 15 sessions of robotic-based training intervention that focuses on the retraining of both motor and somatosensory functions, for a maximum of one hour per session.
|
Patients in the experimental group will be required to move the robotic handle using their paretic arm from the start position to a visual target shown on screen.
However, patients' paretic arm will be occluded from vision throughout the training session.
They will make the reaching movement by depending on their proprioception of the arm position in space, without relying too much on the vision of their arm.
Haptic guidance will be provided as somatosensory cues while participants are actively moving.
Positive reinforcement will also be given for each successful movement that reaches the target in the form of a pleasant audio tone, visual feedback, and a running score.
Assessment will be performed before and after the completion of the whole 15 training sessions.
|
|
Active Comparator: Motor-based training group
Chronic stroke patients will be randomized to receive 15 sessions of robotic-based training intervention that is purely motor based, for a maximum of one hour per session.
|
Patients in the control group will also be required to propel the robotic handle using their paretic arm to a target location.
This training covers the same centre-out reaching movements but without any emphasis on proprioception, where the view of the paretic arm will not be occluded.
However, no haptic guidance will be provided during the reaching movement.
Positive reinforcement will still be given to inform the participants of their trial outcomes.
Assessment will be performed before and after the completion of the whole 15 training sessions.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in motor behavioral scores
Time Frame: Baseline, Post Day 1, Post Day 30 (where the last two sessions will be conducted 1 day and 30 days after the last intervention).
|
A robotic-based assessment to evaluate the movement accuracy of patients' paretic arm.
This will be analyzed through their ability to propel the robotic handle to a target location as straight and as fast as possible.
Key kinematic parameters such as endpoint deviation (cm) and movement smoothness will be computed where larger numbers indicate worse performance.
|
Baseline, Post Day 1, Post Day 30 (where the last two sessions will be conducted 1 day and 30 days after the last intervention).
|
|
Change in somatosensory acuity
Time Frame: Baseline, Post Day 1, Post Day 30 (where the last two sessions will be conducted 1 day and 30 days after the last intervention).
|
A robotic-based assessment to measure performance in proprioception/kinesthesia of patients' paretic arm.
This will be analysed through their ability to first passively sense where the arm is being moved to and later on to reproduce the movement made by the robot.
Key kinematic parameters such as endpoint deviation (cm) will be computed where a larger number indicate worse performance.
|
Baseline, Post Day 1, Post Day 30 (where the last two sessions will be conducted 1 day and 30 days after the last intervention).
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in streamlined Wolf Motor Function Test (WMFT)
Time Frame: Baseline, Post Day 1, Post Day 30 (where the last two sessions will be conducted 1 day and 30 days after the last intervention).
|
Patients' paretic arm performance will be measured by six timed tasks.
For each category, a larger number signifies better performance.
|
Baseline, Post Day 1, Post Day 30 (where the last two sessions will be conducted 1 day and 30 days after the last intervention).
|
|
Change in Erasmus-MC version of the Nottingham Sensory Assessment (EmNSA)
Time Frame: Baseline, Post Day 1, Post Day 30 (where the last two sessions will be conducted 1 day and 30 days after the last intervention).
|
Tactile sensations, sharp-blunt discrimination and proprioception of patients' paretic arm will be assessed.
For each category, a larger number signifies better performance.
|
Baseline, Post Day 1, Post Day 30 (where the last two sessions will be conducted 1 day and 30 days after the last intervention).
|
|
Change in Fugl-Meyer Assessment for Upper Extremity (FMA-UE)
Time Frame: Baseline, Post Day 1, Post Day 30 (where the last two sessions will be conducted 1 day and 30 days after the last intervention).
|
Patients' paretic arm movement ability will be evaluated across different categories of reflex, movement, and coordination.
For each category, a larger number signifies better performance.
|
Baseline, Post Day 1, Post Day 30 (where the last two sessions will be conducted 1 day and 30 days after the last intervention).
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Ananda Sidarta, PhD, research fellow
Publications and helpful links
General Publications
- Bernardi NF, Darainy M, Ostry DJ. Somatosensory Contribution to the Initial Stages of Human Motor Learning. J Neurosci. 2015 Oct 21;35(42):14316-26. doi: 10.1523/JNEUROSCI.1344-15.2015.
- Sidarta A, Vahdat S, Bernardi NF, Ostry DJ. Somatic and Reinforcement-Based Plasticity in the Initial Stages of Human Motor Learning. J Neurosci. 2016 Nov 16;36(46):11682-11692. doi: 10.1523/JNEUROSCI.1767-16.2016.
- Goble DJ. Proprioceptive acuity assessment via joint position matching: from basic science to general practice. Phys Ther. 2010 Aug;90(8):1176-84. doi: 10.2522/ptj.20090399. Epub 2010 Jun 3.
- Sidarta A, Lim YC, Kuah CWK, Loh YJ, Ang WT. Robotic-based ACTive somatoSENSory (Act.Sens) retraining on upper limb functions with chronic stroke survivors: study protocol for a pilot randomised controlled trial. Pilot Feasibility Stud. 2021 Nov 15;7(1):207. doi: 10.1186/s40814-021-00948-3.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NTU-IRB-2019-10-022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
All patient-related information, and data generated by the robotic system will be maintained on a secure server owned by the university.
Access to research records will be limited to primary research team members. Data monitoring will comply with the university policy, guidelines, and data management plan (DMP) approved for the study.
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.